Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia

European Journal of Pharmacology

Volumn 575, Issue 1-3, 2007, Pages 57-65

  Culmsee, Carsten ^a,b   Junker, Vera ^a   Thal, Serge ^c   Kremers, Wolfram ^a   Maier, Sandra ^a   Schneider, Harald Jörn ^d   Plesnila, Nikolaus ^c   Krieglstein, Josef ^a,e  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Adrenoceptor agonist; Cerebral ischemia; Clenbuterol; Glutamate; Neuroprotection; Staurosporine

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUTOXAMINE; CLENBUTEROL; GLUCOCORTICOID; GLUCOSE; GLUTAMIC ACID; NERVE GROWTH FACTOR; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD PRESSURE; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL STRUCTURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG STRUCTURE; ENANTIOMER; ENANTIOSELECTIVITY; EXCITOTOXICITY; GLUCOSE BLOOD LEVEL; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; STELLATE CELL; STROKE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ASTROCYTES; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN ISCHEMIA; CELLS, CULTURED; CLENBUTEROL; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ADRENERGIC, BETA-2; STEREOISOMERISM; TIME FACTORS;

EID: 35348840387     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.066     Document Type: Article

References (32)

1. Bramuglia G.F., and Rubio M.C. Effects of optical isomers of clenbuterol on the relaxant response in rat uterus. Pharm. Res. 43 (2001) 151-154
2. Chen M.J., Nguyen T.V., Pike C.J., and Russo-Neustadt A.A. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell. Signal. 19 (2007) 114-128
3. Chew W., Kucharczyk J., Moseley M., Derugin N., and Norman D. Hyperglycemia augments ischemic brain injury: in vivo MR imaging/spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. Am. J. Neuroradiol. 12 (1991) 603-609
4. Colangelo A.M., Mallei A., Johnson P.F., and Mocchetti I. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res. Mol. Brain Res. 124 (2004) 97-104
5. Culmsee C., Junker V., Kremers W., Thal S., Plesnila N., and Krieglstein J. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 35 (2004) 1197-1202
6. Culmsee C., Semkova I., and Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem. Int. 35 (1999) 47-57
7. Culmsee C., Stumm R.K., Schafer M.K., Weihe E., and Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharm. 379 (1999) 33-45
8. Els T., Klisch J., Orszagh M., Hetzel A., Schulte-Monting J., Schumacher M., and Lucking C.H. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc. Dis. 13 (2002) 89-94
9. Enna S., Malick J.B., and Richelson E. Antidepressants: Neurochemical, Behavioral and Clinical Perspectives (1981), Raven Press, New York
10. Flack H.D. On enantiomorph-polarity estimation. Acta Crysallogr. A39 (1983) 876-881
11. Follesa P., and Mocchetti I. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol. 43 (1993) 132-138
12. Gupta M.K., and Singh M. Evidence based review on levosalbutamol. Indian J. Pediatr. 7 (2007) 161-167
13. Hatton G.I., Luckman S.M., and Bicknell R.J. Adrenalin activation of beta 2-adrenoceptors stimulates morphological changes in astrocytes (pituicytes) cultured from adult rat neurohypophyses. Brain Res. Bull. 26 (1991) 765-769
14. Hayes V.Y., Isackson P.J., Fabrazzo M., Follesa P., and Mocchetti I. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp. Neurol. 132 (1995) 33-41
15. Illera J.C., Silvan G., Blass A., Martinez M.M., and Illera M. The effect of clenbuterol on adrenal function in rats. Analyst 123 (1998) 2521-2524
16. Junker V., Becker A., Huhne R., Zembatov M., Ravati A., Culmsee C., and Krieglstein J. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur. J. Pharmacol. 446 (2002) 25-36
17. Maltin C.A., Delday M.I., Hay S.M., Smith F.G., Lobley G.E., and Reeds P.J. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci. Rep. 7 (1987) 143-149
18. Martin P., Puech A.J., Brochet D., Soubrie P., and Simon P. Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to beta-agonists. Eur. J. Pharmacol. 117 (1985) 127-129
19. Murugaiah K.D., and O'Donnell J.M. Clenbuterol increases norepinephrine release from rat brain slices by a calcium- and receptor-independent mechanism. Res. Commun. Mol. Pathol. Pharmacol. 86 (1994) 311-324
20. Murugaiah K.D., and O'Donnell J.M. Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices. Res. Commun. Mol. Pathol. Pharmacol. 90 (1995) 179-190
21. Parsons M.W., Barber P.A., Desmond P.M., Baird T.A., Darby D.G., Byrnes G., Tress B.M., and Davis S.M. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol. 52 (2002) 20-28
22. Pflugrath J.W. The finer things in X-ray diffraction data collection. Acta crystallogr., D Biol. Crystallogr. 55 (1999) 1718-1725
23. 2O)Cl. Zeitschr. f. Kristallogr. New Cryst. Struct. 220 (2005) 180-182
24. Semkova I., Schilling M., Henrich-Noack P., Rami A., and Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 717 (1996) 44-54
25. Sheldrick G.M. Crystallographic computing. In: Sheldrick G.M., Kruger C., and Goddard R. (Eds). Crystallographic Computing (1985), Oxford University Press 175-189
26. Troadec J.D., Marien M., Mourlevat S., Debeir T., Ruberg M., Colpaert F., and Michel P.P. Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol. Pharmacol. 62 (2002) 1043-1052
27. von Deutsch D.A., Abukhalaf I.K., Wineski L.E., Aboul-Enein H.Y., Pitts S.A., Parks B.A., Oster R.A., Paulsen D.F., and Potter D.E. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality 12 (2000) 637-648
28. Waldeck B., and Widmark E. Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of clenbuterol. Acta Pharm. Toxicol. 56 (1985) 221-227
29. Xiong Z.G., Zhu X.M., Chu X.P., Minami M., Hey J., Wei W.L., MacDonald J.F., Wemmie J.A., Price M.P., Welsh M.J., and Simon R.P. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118 (2004) 687-698
30. Zafra F., Lindholm D., Castren E., Hartikka J., and Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J. Neurosci. 12 (1992) 4793-4799
31. Zhu Y., Culmsee C., Semkova I., and Krieglstein J. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 18 (1998) 1032-1039
32. Zhu Y., and Krieglstein J. β2-adrenoceptor agonist clenbuterol causes NGF expression and neuroprotection. CNS Drug Rev. 5 (1999) 347-364